[{"address1": "42127 Pleasant Forest Court", "city": "Ashburn", "state": "VA", "zip": "20148-7349", "country": "United States", "phone": "703 980 4182", "website": "https://quoinpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael  Myers Ph.D.", "age": 63, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1053788, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Denise  Carter", "age": 56, "title": "Co-Founder, COO & Director", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 858245, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sally  Lawlor", "title": "Chief Financial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.42, "open": 9.09, "dayLow": 8.53, "dayHigh": 9.499, "regularMarketPreviousClose": 9.42, "regularMarketOpen": 9.09, "regularMarketDayLow": 8.53, "regularMarketDayHigh": 9.499, "payoutRatio": 0.0, "beta": 1.873, "forwardPE": -1.5513512, "volume": 10522, "regularMarketVolume": 10522, "averageVolume": 59950, "averageVolume10days": 21180, "averageDailyVolume10Day": 21180, "bid": 7.46, "ask": 10.2, "bidSize": 1, "askSize": 1, "marketCap": 13915309, "fiftyTwoWeekLow": 5.01, "fiftyTwoWeekHigh": 41.8, "allTimeHigh": 1417500.0, "allTimeLow": 5.01, "fiftyDayAverage": 11.3672, "twoHundredDayAverage": 10.03119, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 249886768, "profitMargins": 0.0, "floatShares": 5424154, "sharesOutstanding": 1616179, "sharesShort": 27827, "sharesShortPriorMonth": 29780, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.0172, "heldPercentInsiders": 0.03585, "heldPercentInstitutions": 0.55856997, "shortRatio": 0.72, "shortPercentOfFloat": 0.0177, "impliedSharesOutstanding": 1616180, "bookValue": -2.065, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -13767556, "trailingEps": -29.17, "forwardEps": -5.55, "lastSplitFactor": "1:35", "lastSplitDate": 1744156800, "enterpriseToEbitda": -17.754, "52WeekChange": -0.22580647, "SandP52WeekChange": 0.11527538, "quoteType": "EQUITY", "currentPrice": 8.61, "targetHighPrice": 70.0, "targetLowPrice": 25.0, "targetMeanPrice": 40.66667, "targetMedianPrice": 27.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 5412678, "totalCashPerShare": 0.184, "ebitda": -14075342, "totalDebt": 2473733, "quickRatio": 0.939, "currentRatio": 1.044, "returnOnAssets": -0.99474, "returnOnEquity": -6.51401, "freeCashflow": -5690525, "operatingCashflow": -10742488, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "QNRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Quoin Pharmaceuticals, Ltd.", "averageDailyVolume3Month": 59950, "fiftyTwoWeekLowChange": 3.5999994, "fiftyTwoWeekLowChangePercent": 0.7185627, "fiftyTwoWeekRange": "5.01 - 41.8", "fiftyTwoWeekHighChange": -33.19, "fiftyTwoWeekHighChangePercent": -0.7940191, "fiftyTwoWeekChangePercent": -22.580647, "dividendDate": 1571788800, "earningsTimestampStart": 1754483400, "earningsTimestampEnd": 1754915400, "earningsCallTimestampStart": 1710419400, "earningsCallTimestampEnd": 1710419400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -29.17, "epsForward": -5.55, "epsCurrentYear": -11.6, "priceEpsCurrentYear": -0.7422413, "fiftyDayAverageChange": -2.7572002, "fiftyDayAverageChangePercent": -0.24255756, "twoHundredDayAverageChange": -1.4211903, "twoHundredDayAverageChangePercent": -0.14167714, "priceToBook": -4.1694913, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Cellect Biotechnology Ltd.", "nameChangeDate": "2026-02-21", "shortName": "Quoin Pharmaceuticals, Ltd.", "cryptoTradeable": false, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1771634393, "regularMarketTime": 1771621200, "exchange": "NCM", "messageBoardId": "finmb_593010770", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -8.59873, "regularMarketPrice": 8.61, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1470058200000, "postMarketChangePercent": 4.529621, "postMarketPrice": 9.0, "postMarketChange": 0.39000034, "regularMarketChange": -0.81, "regularMarketDayRange": "8.53 - 9.499", "fullExchangeName": "NasdaqCM", "displayName": "Quoin Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]